Scientific resource
Blog
Blog
19/11/2024
Medicinal Chemist’s Insights into the Microbiome
Here, we highlight the need to consider early the microbiome in drug discovery, as it may influence drug responses, therefor efficacy
Blog
10/10/2024
The Game-Changing Role of Artificial Intelligence in Drug Discovery
Discover in this blog how Artificial Intelligence (AI) has a game-changing role in drug discovery and computational chemistry
Blog
24/09/2024
Radionuclides: a sourcing challenge
In this blog, we deal with overcoming radionuclides supply challenges with innovative solutions by Oncodesign Services
Blog
03/04/2024
Next frontier in cancer: deep dive into oncolytic viruses
In this blog, we pay attention in the development of oncolytic viruses (OVs) which destroy cancer cells and leverage the host immune system to enhance the effect.
Blog
01/12/2023
How to repurpose your cancer drug to a Molecular RadioTherapy drug candidate
In this blog, Dr Eftychia Koumarianou deals with the ground-breaking and intriguing approach that hides behind the theranostics.
Blog
17/10/2023
Targeted RNA degradation: Principle and Therapeutic Promises
RNA, or RiboNucleic Acid, is a structured macromolecule which plays a central role in numerous cellular functions.
Blog
19/09/2023
Breaking Barriers in Oncology Drug Development: Unveiling the Potential of 3D Cell Models for Drug Discovery
Blog: 3D Cell models are revolutionizing Cancer Drug Development. Here, we present the main advantages to better understand tumor complexity
Blog
11/07/2023
CADD: computer tools and chemists combine to make better drug leads
Sylvain Lozano, computational chemist, explains the important role these tools play in our drug discovery journey.
Blog
29/06/2023
Why you should consider tumor microenvironment for cancer therapy?
Combination of Tumor microenvironment and modulating therapeutic approaches may be required to overcome the resistance to treatments and prevent tumor recurrence.
Blog
15/06/2023
How to mimic long COVID for drug discovery?
Long COVID is a complex multisystemic condition still poorly understood. Using optimal preclinical models is essential to understand their mechanisms better and develop new treatments.
Blog
17/05/2023
Five Reasons why you should switch to digital PCR (dPCR)
Digital PCR has enhanced characteristics over qPCR across both its Protocols and Applications, including higher precision and sensitivity. Learn more here.
Blog
09/05/2023
Covalent drugs and the potential of benzoxaboroles
Molecules based on boron and benzoxaboroles are exciting as reversible covalent binders to target the serine and threonine proteome.